SEP 29, 2019 2:57 PM PDT

CBD Alleviates Angelman Syndrome Seizures in Mice Trial

WRITTEN BY: Julia Travers

CBD has already been shown to be effective as an anti-anxiety, antipsychotic and anti-epileptic substance. Can it help youth and adults with a rare neurological condition?

Cannabidiol (CBD) can lessen seizure severity in mice that genetically model Angelman syndrome, a rare neurodevelopmental condition. This condition is characterized by brain rhythm dysfunction, intellectual disability, lack of speech and, in many cases, drug-resistant epilepsy. The effectiveness of CBD was tested by University of North Carolina at Chapel Hill (UNC) School of Medicine researchers.

In the lab of Ben Philpot, the team tested the effects of CBD on seizures, brain activity abnormalities and motor deficit in mice that genetically model Angelman syndrome. According to EurekAlert, the Philpot lab creates genetically modified mouse models of neurodevelopmental disorders and uses them to look for new treatments for diseases including Rett, Pitt-Hopkins and Angelman syndromes.

One injection of CBD was found to substantially lessen seizure severity, when the seizures were triggered by loud sound or elevated body temperature. A typical dose of 100 mg/kg of CBD did lead to mild mouse sedation, but it had minimal impact on their balance or coordination. And, CBD reinstituted normal brain rhythms.

"We're confident our study provides the preclinical framework necessary to better guide the rational development of CBD as a therapy to help lessen seizures associated with Angelman syndrome and other neurodevelopmental disorders," Bin Gu, PhD, first author and postdoctoral fellow in the Philpot lab, said.

"There is an unmet need for better treatments for kids with Angelman syndrome to help them live fuller lives and to aid their families and caregivers. Our results show CBD could help the medical community safely meet this need," Ben Philpot, PhD, said.

 

“Cannabidiol attenuates seizures and EEG abnormalities in Angelman syndrome model mice,” was published in the Journal of Clinical Investigation.

 

Article Source: EurekAlert, Journal of Clinical Investigation

 

About the Author
  • Julia Travers is a writer, artist and teacher. She frequently covers science, tech, conservation and the arts. She enjoys solutions journalism. Find more of her work at jtravers.journoportfolio.com.
You May Also Like
APR 03, 2020
Cannabis Sciences
Nope, Marijuana Does Not Cure COVID-19
APR 03, 2020
Nope, Marijuana Does Not Cure COVID-19
As the COVID-19 pandemic has fueled panic across the world amid global lockdowns and spiking death tolls, some have star ...
APR 05, 2020
Cannabis Sciences
Rats Develop Drug-Seeking Behavior After Cannabis Withdrawal
APR 05, 2020
Rats Develop Drug-Seeking Behavior After Cannabis Withdrawal
A recent study from Washington State University has found that rats with regular access to cannabis tend to show drug-se ...
MAY 16, 2020
Cannabis Sciences
Body's Own Cannabis Helps Us Forget Traumatic Events
MAY 16, 2020
Body's Own Cannabis Helps Us Forget Traumatic Events
Researchers have found that anandamide, often referred to as the body’s own cannabis, may help us forget traumatic ...
JUL 02, 2020
Cannabis Sciences
What is the Difference Between CBD and CBG?
JUL 02, 2020
What is the Difference Between CBD and CBG?
Like cannabidiol (CBD), cannabigerol (CBG) is a cannabinoid. Both compounds are found in cannabis plants. Both are also ...
JUL 26, 2020
Cannabis Sciences
Medicinal Cannabis Kills Cancer Cells
JUL 26, 2020
Medicinal Cannabis Kills Cancer Cells
Researchers at the University of Newcastle have found that a modified version of medicinal cannabis can kill and inhibit ...
JUL 29, 2020
Cannabis Sciences
Stimulants, Cannabis, and Medical Cannabis Laws
JUL 29, 2020
Stimulants, Cannabis, and Medical Cannabis Laws
Lesbian, gay, and bisexual populations may be at a higher risk of prescription stimulant use, based on a new examination ...
Loading Comments...